Lin F - Search Results

1

Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.

He Y, Lin F, Chipman PR, Bator CM, Baker TS, Shoham M, Kuhn RJ, Medof ME, Rossmann MG. He Y, et al. Among authors: lin f. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10325-9. doi: 10.1073/pnas.152161599. Epub 2002 Jul 15. Proc Natl Acad Sci U S A. 2002. PMID: 12119400 Free PMC article.

2

Solution structure of a functionally active fragment of decay-accelerating factor.

Uhrinova S, Lin F, Ball G, Bromek K, Uhrin D, Medof ME, Barlow PN. Uhrinova S, et al. Among authors: lin f. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4718-23. doi: 10.1073/pnas.0730844100. Epub 2003 Apr 2. Proc Natl Acad Sci U S A. 2003. PMID: 12672958 Free PMC article.

3

Interaction of decay-accelerating factor with coxsackievirus B3.

Hafenstein S, Bowman VD, Chipman PR, Bator Kelly CM, Lin F, Medof ME, Rossmann MG. Hafenstein S, et al. Among authors: lin f. J Virol. 2007 Dec;81(23):12927-35. doi: 10.1128/JVI.00931-07. Epub 2007 Sep 5. J Virol. 2007. PMID: 17804498 Free PMC article.

4

Interaction of decay-accelerating factor with echovirus 7.

Plevka P, Hafenstein S, Harris KG, Cifuente JO, Zhang Y, Bowman VD, Chipman PR, Bator CM, Lin F, Medof ME, Rossmann MG. Plevka P, et al. Among authors: lin f. J Virol. 2010 Dec;84(24):12665-74. doi: 10.1128/JVI.00837-10. Epub 2010 Sep 29. J Virol. 2010. PMID: 20881044 Free PMC article.

5

Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis.

Lin F, Emancipator SN, Salant DJ, Medof ME. Lin F, et al. Lab Invest. 2002 May;82(5):563-9. doi: 10.1038/labinvest.3780451. Lab Invest. 2002. PMID: 12003997 Free article.

6

Resonance assignments of the central complement control protein module pair of human decay accelerating factor.

Uhrínová S, Lin F, Uhrín D, Medof ME, Barlow PN. Uhrínová S, et al. Among authors: lin f. J Biomol NMR. 2002 Jun;23(2):167-8. J Biomol NMR. 2002. PMID: 12153048 No abstract available.

7

Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia.

Kaminski HJ, Kusner LL, Richmonds C, Medof ME, Lin F. Kaminski HJ, et al. Among authors: lin f. Exp Neurol. 2006 Dec;202(2):287-93. doi: 10.1016/j.expneurol.2006.06.003. Epub 2006 Jul 20. Exp Neurol. 2006. PMID: 16859686

8

Bulk production and functional analyses of mouse CD55's native and deglycosylated active domains.

Lin F, Immormino RM, Shoham M, Medof ME. Lin F, et al. Arch Biochem Biophys. 2001 Sep 1;393(1):67-72. doi: 10.1006/abbi.2001.2488. Arch Biochem Biophys. 2001. PMID: 11516162

9

Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection.

Lin F, Kaminski HJ, Conti-Fine BM, Wang W, Richmonds C, Medof ME. Lin F, et al. J Clin Invest. 2002 Nov;110(9):1269-74. doi: 10.1172/JCI16086. J Clin Invest. 2002. PMID: 12417565 Free PMC article.

10

Decay-accelerating factor modulates induction of T cell immunity.

Heeger PS, Lalli PN, Lin F, Valujskikh A, Liu J, Muqim N, Xu Y, Medof ME. Heeger PS, et al. Among authors: lin f. J Exp Med. 2005 May 16;201(10):1523-30. doi: 10.1084/jem.20041967. Epub 2005 May 9. J Exp Med. 2005. PMID: 15883171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,065 results

Search Page

Filters